Summary

Synthetic Condensates and Cell-Like Architectures from Amphiphilic DNA Nanostructures

Published: May 31, 2024
doi:

Summary

We present a protocol for preparing synthetic biomolecular condensates consisting of amphiphilic DNA nanostars starting from their constituent DNA oligonucleotides. Condensates are produced from either a single nanostar component or two components and are modified to sustain in vitro transcription of RNA from an embedded DNA template.

Abstract

Synthetic droplets and condensates are becoming increasingly common constituents of advanced biomimetic systems and synthetic cells, where they can be used to establish compartmentalization and sustain life-like responses. Synthetic DNA nanostructures have demonstrated significant potential as condensate-forming building blocks owing to their programmable shape, chemical functionalization, and self-assembly behavior. We have recently demonstrated that amphiphilic DNA “nanostars”, obtained by labeling DNA junctions with hydrophobic moieties, constitute a particularly robust and versatile solution. The resulting amphiphilic DNA condensates can be programmed to display complex, multi-compartment internal architectures, structurally respond to various external stimuli, synthesize macromolecules, capture and release payloads, undergo morphological transformations, and interact with live cells. Here, we demonstrate protocols for preparing amphiphilic DNA condensates starting from constituent DNA oligonucleotides. We will address (i) single-component systems forming uniform condensates, (ii) two-component systems forming core-shell condensates, and (iii) systems in which the condensates are modified to support in vitro transcription of RNA nanostructures.

Introduction

Synthetic cells are micrometer-scale (10-50 µm) devices constructed from the bottom-up to replicate functions and structures of extant biological cells1,2. Synthetic cells are often bound by membranes constructed from lipid bilayer vesicles3,4,5,6,7, polymersomes8,9, or proteinosomes10,11, which can also be used to establish internal compartmentalisation12,13. Inspired by the membrane-less organelles known to sustain various functionalities in living cells14, structures such as polymer coacervates, biomolecular condensates, and hydrogels are gaining traction as versatile and robust alternatives to establish both external and internal compartmentalization in synthetic cells15,16,17,18.

Leveraging the versatile toolkit of DNA nanotechnology19, multiple solutions have been developed to engineer synthetic droplets and condensates from the self-assembly of artificial DNA nanostructures, whose size, shape, functionality, valency, and mutual interactions can be precisely programmed20. DNA droplets or condensates are biocompatible and can act as scaffolds for both synthetic cells and organelles, hosting chemical and biomolecular reactions21, computing information22,23, capturing and releasing cargoes24,25, and sustaining structural responses26.

Among the diverse designs of condensate-forming DNA nanostructures, amphiphilic DNA nanostars – dubbed C-stars have proven robust and versatile27. C-stars are simple branched motifs consisting of a fixed DNA junction (typically four-way), from which double-stranded (ds)DNA arms emerge28. The arms are then tipped with hydrophobic moieties, typically cholesterol, rendering the nanostructures amphiphilic and driving their condensation following a straightforward one-pot annealing. C-star condensates afford precise structural and functional programmability, including the possibility of establishing multi-compartment architectures29,30, structurally responding to DNA and cation triggers31, synthesizing macromolecules29, capturing and releasing payloads32, and interacting with live cells33. Below, we will describe and discuss protocols to produce C-star condensates starting from their constituent oligonucleotides.

The protocol summarizes the preparation of unary (one-component) and binary (two-component) condensates, utilizing three different C-star designs (Figure 1) -"Non-responsive", "TMSD-responsive", and "RNA-templating". The "Non-responsive" C-star (panel A) consists of four "core strands" with distinct sequences forming the four-way junction. Four identical cholesterol-modified oligonucleotides are connected to the junction, ensuring that a cholesterol molecule is present at the end of each arm. The non-responsive C-stars constitute simple, inert scaffolds for unary and binary condensates. In the "TMSD-responsive" C-star (panel B), the connection between the cholesterolised strands and the junction is ensured by a "Toeholding bridge" strand, which features a dangling single-stranded (ss)DNA "toehold" domain. In the presence of an invader DNA strand with a complementary toehold domain, a toehold-mediated strand displacement reaction can be triggered34, whereby the invader displaces the Toeholding bridge, breaking the connection between the junction and the hydrophobic moieties and triggering the disassembly of the DNA network32. Finally, the "RNA templating" C-star (panel C) includes a "Base" modification complementary to a "Bridge" strand, the latter of which links the transcribable ssDNA template for the Broccoli aptamer29. Sequence details of the constituent oligonucleotides for the three types of C-star designs mentioned here can be found in Supplementary Table 1 and across previous works29,30,32.

Figure 1
Figure 1. Schematics of three different designs of amphiphilic DNA nanostars (C-stars). Oligonucleotide sequences for various examples of the C-stars described here can be found in Supplementary Table 1. (A) Schematic of a C-star designed to form non-responsive condensates, with the component oligonucleotide strands "Core 1", "Core 2", "Core 3", "Core 4", (coloured in shades of pink) and "Terminal cholesterol" (coloured in blue). Each unique colour represents an oligonucleotide strand of unique sequence. "Core 1" and "Core 3" are each partially complementary to "Core 2" and "Core 4", but non-complementary to each other. (B) Schematic of a C-star designed to disassemble upon the addition of an invading strand via toehold-mediated strand displacement, as described in previous work32. This C-star is composed of "Core" and "Terminal cholesterol" strands (coloured in grey) as well as a "Terminal complement" (shown in orange) and a "Toeholding bridge" strand (shown in dark teal). The latter contains a six-nucleotide overhang to which an appropriately designed invader strand can bind and subsequently entirely displace the "Toeholding bridge" strand, which causes the dissociation of the central nanostar junction (composed of "Core 1, 2, 3, and 4") from the duplexes composed of the "Terminal complement" and "Terminal cholesterol" strands. (C) Schematic of a C-star functionalised with a DNA template for an RNA aptamer. This, too, is composed of the "Terminal cholesterol" strand and "Core 2, 3, and 4" (all shown in grey), as well as an extended version of the "Core 1" strand (shown in pink), a "Base" strand (brown), a "Bridge" strand (yellow), and the "Aptamer template" (green). The DNA duplex composed of the latter two strands forms the T7 polymerase promoter region, which marks the transcription start site. Please click here to view a larger version of this figure.

C-star condensates form upon thermal annealing of the constituent oligonucleotides, which in the protocol presented here is conducted within sealed glass capillaries with a high aspect ratio rectangular cross-section. These containers offer multiple key advantages: i) Sealing ensures that evaporation is completely prevented over the (sometimes slow) annealing steps; ii) The optical-quality flat bottom of the capillaries enables imaging of the self-assembly (or disassembly) transient; iii) the high aspect ratio of the capillaries ensures that heavy condensates settle over a wide, flat area, reducing chances of coalescence and aggregation at later stages of the self-assembly transient that would occur in wedge-shaped containers (e.g., microcentrifuge tubes), and producing relatively monodisperse condensate populations; iv) performing the annealing in an elongated glass capillary minimizes exposure of the sample to hydrophobic interfaces (air, plastic or oil), which have been observed to perturb self-assembly by recruiting the amphiphilic cholesterolised oligonucleotides. Once the assembly protocol is completed, condensates can be extracted from glass capillaries for further experiments that involve additional reagents.

Protocol

NOTE: The protocol is divided into three sections. Section 1 describes the prerequisite steps, including the preparation of DNA oligonucleotides and glass capillaries. Section 2 describes the preparation of C-star condensates of various designs, including one- and two-component designs, and their extraction from the glass capillaries. Section 3 describes the use of one-component RNA templating C-star condensates for the synthesis of an RNA aptamer. The user must follow good lab practice throughout, ensure that all necessary risk assessments and mitigations are in place, and wear appropriate personal protective equipment (PPE), including gloves, safety glasses, and a lab coat. The cleaning of glass capillary tubes requires their sonication, first in a surfactant solution and second in isopropanol or ethanol. The extraction of C-star condensates from capillary tubes requires the use of a diamond scribing pen to score and snap the glass, with an associated risk of injury from glass fragments. Key materials, equipment, and reagents used are listed in the Table of Materials. Most non-functionalized oligonucleotides are purified by the supplier using standard desalting, with the exception of the "extended Core 1" and "Aptamer template" strands, which are ordered with polyacrylamide gel electrophoresis (PAGE) purification. Cholesterol-modified oligonucleotides are purified by the supplier using reverse-phase high-performance liquid chromatography (HPLC).

1. Prerequisites

NOTE: The following solutions should be prepared in ultrapure (Type I) water and filtered using 0.22 µm syringe filters: Tris-EDTA (TE) buffer, comprising 10 mM Tris, 1 mM EDTA, at pH ~8.0; TE buffer supplemented with 2 M NaCl; and TE buffer supplemented with 0.3 M NaCl. Buffer solutions should be used within 2 weeks of preparation and stored at 4 °C when not in use. In addition, a 1 vol% solution of alkaline optical detergent in ultrapure water will be used for cleaning the glass capillaries.

  1. Preparation of DNA oligonucleotides from lyophilized state
    1. Briefly centrifuge (2000 x g for 10-30 s) the tubes of lyophilized DNA oligonucleotides to ensure pellets of lyophilized DNA collect at the bottom.
      NOTE: The centrifugation is done at room temperature (RT) for 10-30 s. The mini centrifuge used here defaults to 2000 x g (6000 rpm).
    2. Add the appropriate amount of TE buffer to reconstitute each oligonucleotide at 100 µM. Vortex thoroughly to ensure complete dissolution, then spin down tubes to collect all liquid as per step 1.1.1.
    3. For each stock solution, measure absorbance at 260 nm and calculate the final concentration using the extinction coefficient of the oligonucleotide sequence under test.
      NOTE: The extinction coefficient for a given oligonucleotide sequence is usually found on the supplier's Data Sheet but can also be calculated with online tools using the nearest neighbor model35 or tabulated values of the extinction coefficient of individual nucleotides36.
    4. Store the rehydrated oligonucleotides at 4 °C for short periods of time (up to 1 week) or at -20 °C for longer-term storage (up to 6 months).
  2. Cleaning of glass capillary tubes
    1. Sonicate in 1% alkaline optical detergent for optical components in deionized water.
      1. Take the required number of glass capillary tubes to be cleaned and place them into a tall, narrow container (e.g., a beaker or a 15/50 mL centrifuge tube) such that the capillaries do not lie flat on the base of the container.
      2. Add the detergent to the container, filling it just above the level of the capillary tubes. Ensure there are no trapped air bubbles inside the capillary tubes – tap to remove, if necessary. Loosely cover the container (e.g., in tin foil or using the centrifuge tube lid, ensuring it is not tightly sealed).
      3. Set a sonicating water bath to 40 °C, place the covered container upright into the bath, and sonicate for 30 min. Ensure the foil, if used, does not come into contact with the water in the sonicating bath.
        NOTE: The sonicating bath used in this study defaults to a sonication frequency of 60 Hz and a sonication power of 150 W.
        CAUTION: Never add or remove items from a sonicating bath while running; always pause the protocol first.
      4. Once sonication is complete, turn off the heating element of the sonicating water bath, then thoroughly rinse the capillaries in the container with deionized or ultrapure water – a minimum of five times, discarding the rinsing water each time.
  3. Sonicate in isopropanol or ethanol.
    1. To the glass capillary tubes in the cleaning container, add isopropanol or ethanol (minimum 70%), filling to just above the level of the capillary tubes. As in step 1.2.1.2, ensure there are no trapped air bubbles in the capillary tubes and loosely cover the container.
    2. Place the container upright into the sonicating bath and sonicate for 15-30 min.
      CAUTION: Isopropanol and ethanol are flammable, with flash points below RT. Minimize the volumes of solvents used during cleaning by choosing a container of appropriate size, ensure that the containers are loosely covered, and do not leave the sonicating bath unattended during this stage.
    3. Once sonication is complete, appropriately dispose of the isopropanol or ethanol and dry the capillaries under nitrogen, handling them with a lint-free tissue.

2. Preparation and extraction of C-star condensates (Figure 2)

Figure 2
Figure 2: Loading C-star mixtures and extracting condensates from glass capillary tubes. In all panels, the C-star mixture has been replaced with an aqueous solution of 25 mM calcein to aid visibility. (AE) Key steps, in order, to be taken prior to annealing, corresponding to protocol sections 2.1 and 2.2. (FJ) Key steps, in order, to be taken after annealing, corresponding to protocol section 2.3. During extraction (panels (IJ)), DNA condensates will sediment from the capillary into the buffer reservoir as long as the microcentrifuge tube is stored vertically. Condensates will not be visible to the naked eye. Please click here to view a larger version of this figure.

  1. Preparation of C-star mixtures for single-component condensates
    NOTE: Sequence details for various designs of single components can be found in Supplementary Table 1 and across previous works29,30,32. The slow annealing protocols defined in steps 2.1.9 and 2.2.2 were developed to ensure the relaxation of the nanostar networks into compact morphologies, given the strongly temperature-dependent rheological properties of nanostar networks37.
    1. Oligonucleotide and buffer components will vary depending on the C-star design desired. Prepare a 60 µL mixture of single-component C-star condensates at 5 µM concentration for either the non-responsive four-arm C-star, the TMSD-responsive C-star, or the RNA-templating C-star.
    2. For each design, pipette the appropriate components listed in Supplementary Table 2 into a separate microcentrifuge tube and mix thoroughly via pipetting.
      NOTE: All oligonucleotide stock solutions are assumed to be at 100 µM concentration in TE.
    3. Withdraw the entire 60 µL of C-star solution and pipette carefully to inject the mixture into the cleaned, dry glass capillary tube as shown in Figure 2A, taking care to avoid the introduction of air bubbles.
    4. Using a pipette, inject approximately 9-12 µL of mineral oil into each end of the capillary tube, capping the sample such that there is no free interface between the C-star solution and the air (see Figure 2B). Then, carefully dry the capillary tube with tissue paper to ensure no oil is present on the outside of it (Figure 2C), taking care not to wick mineral oil or C-star solution out of the capillary tube. The end result is demonstrated in Figure 2D.
    5. Prepare a small batch of two-part epoxy glue to adhere each end of the capillary tube, flat side down, to a glass cover slip. Ensure the openings of the tube are completely covered in glue, forming a continuous seal, as shown in Figure 2E.
    6. Set aside to cure for a minimum of 3 h, but preferably overnight.
    7. After ~30 min of curing, inspect the glue layer for the presence of gaps in the seal caused by air bubbles. If these are present, seal them using a small quantity of glue.
    8. Wrap the capillary tube glued to the coverslip in tin foil, ensuring the foil is kept flat at the underside of the glass cover slip. The foil ensures good thermal contact between the same and the heating element of the thermal cycler (see next step).
    9. Place the wrapped sample into a thermal cycler and anneal using the following protocol: Hold at 95 °C for 30 min, then cool from 85 °C to 50 °C at -0.04 °C·min-1, and then cool from 50 °C to RT at -0.5 °C·min-1.
      1. Store the annealed C-star condensates at 4 °C or RT for extended periods (months) as long as the capillary remains sealed, as the thermal annealing effectively sterilizes the sample and denatures nucleases. Keep the capillary flat during storage and handling to prevent condensates from sedimenting towards one end and aggregating.
  2. Preparation of C-star mixtures for binary condensates
    ​NOTE: To inform the selection of C-star populations for binary systems, refer to the work by Malouf et al., which describes the design rules and expected phase behavior of binary C-star condensates30.
    1. To prepare binary condensates, combine 30 µL volumes of the C-star mixtures described in step 2.1 above to a total volume of 60 µL, mix thoroughly, load into capillaries, and follow steps 2.1.4-2.1.8.
    2. Place the wrapped sample into a thermal cycler and anneal using the following protocol: Hold at 95 °C for 30 min, then cool from 85 °C to 40 °C at -0.01 °C·min-1, and then cool from 40 °C to RT at -0.1 °C·min-1.
  3. Extraction of C-star condensates from capillary tubes.
    1. Prepare a large (1.5 mL or 2.0 mL) microcentrifuge tube containing 60 µL of 0.3 M NaCl in TE buffer.
    2. Unwrap the capillary sample and use a diamond scribing pen to score the underside of the coverslip at each inner end of the glued area (Figure 2F). Break off the coverslip in this region and discard appropriately.
    3. Thoroughly clean the capillary tubes with ethanol and dry.
    4. Score each end of the capillary tubes with the diamond scribing pen, first with the underside (Figure 2G), then flipping and scoring the tubes "right side up".
      1. Ensure that the score lines do not overlap the oil-water interface. They must be within the aqueous region to prevent oil from remaining in the extracted sample.
    5. Snap off the ends of the capillary tubes (Figure 2H), retaining the central part of the tube and discarding the rest. Place the cut capillary tube into the microcentrifuge tube prepared in step 2.3.1, ensuring that the bottom of the capillary tube makes contact with the buffer solution (Figure 2I).
    6. The condensates will sediment from the tube into the buffer reservoir through gravity; allow this to take place for a minimum of 10 min (Figure 2J). Remove the cut capillary tube and discard it appropriately. This gentle extraction approach limits the risk of condensate aggregation.

3. Transcription of an RNA aptamer from RNA-templating C-star condensates

NOTE: For the production of the Broccoli RNA aptamer, a solution of difluoro-4-hydroxybenzylidene imidazolidinone (DFHBI) is required – DFHBI powder is first prepared as a stock solution at 10 mM in dimethyl sulfoxide (DMSO), which is then diluted to 600 µM in RNase- and DNase- free water.

  1. Washing RNA-templating C-star condensates
    NOTE: RNA-templating C-star condensates are washed three times to ensure unbound template oligonucleotides are removed.
    1. Allow the solution of extracted condensates to settle for at least 5 min, and then remove approximately half the volume of the supernatant.
      1. For a 60 µL volume of extracted condensates, remove between 25-30 µL of the supernatant.
      2. Pipette from the top of the liquid level to minimize the number of condensates removed during this step.
    2. Add the same volume of 0.3 M NaCl in TE to replace the removed supernatant and mix by pipetting.
    3. Repeat the previous two steps for a total of three cycles.
  2. Preparation of T7 transcription mixture
    ​NOTE: The T7 transcription mixture is prepared using the CellScript T7-FlashScribe Transcription Kit. Step 3.2.2 is a modification of the manufacturer's protocol, which can be found here38. Here we describe the transcription of the Broccoli RNA aptamer, which induces fluorescence in DFHBI upon binding. For other light-up aptamers, replace the volume of DFHBI described in step 3.2.2 with the appropriate fluorogen. For other transcripts, remove this component entirely.
    1. Prepare a stock solution of 10 mM DFHBI in DMSO, then dilute an aliquot to an end concentration of 600 µM using RNase- and DNase- free water.
    2. Defrost the transcription kit components on ice and then pipette the following into an autoclaved microcentrifuge tube at room temperature using sterile pipette tips: 2 µL of 10x T7-Transcription Buffer (provided in the transcription kit), 1.8 µL of 100 mM ATP, 1.8 µL of 100 mM CTP, 1.8 µL of 100 mM UTP, 1.8 µL of 100 mM GTP, 2 µL of 100 mM DTT, 2 µL of 600 µM DFHBI, 0.5 µL of RNase inhibitor, 2 µL of T7-enzyme solution (provided in the transcription kit).
    3. Gently mix the solution by pipetting.
    4. Use transcription mixture for step 3.3 (synthesis of RNA transcript) immediately after preparing.
  3. Synthesis of RNA transcript
    1. Into a chamber suitable for microscopy imaging, pipette 3.3 µL of the washed condensates prepared from RNA-templating C-stars and add the total volume of the transcription mixture prepared prior.
    2. Acquire microscopy images for a duration of 18 h, starting immediately after adding the transcription mixture to the condensates.
      NOTE: Microscopy settings will depend on the system prepared. Ensure that the appropriate excitation and emission settings are used for any fluorophores in the sample, along with exposure times that will not lead to saturation as transcription progresses. As for any time-lapse, a compromise should be found between a high enough laser or LED power for a good signal while also minimising the risk of photobleaching. Photobleaching over long periods of time will be minimised on LED-based systems compared to laser-based systems. Suggested imaging intervals: 20 min for the first 2 h, and 30 min subsequently.

Representative Results

After annealing, C-star condensates can be imaged directly in the capillary tube, or after extraction, to confirm their formation. For all C-star design variations, one should observe distinct spherical or polyhedral condensates approximately 10-50 µm in diameter, the latter forming when crystallization occurs28,32. For single-component condensates, the condensates should be discrete and uniform in appearance, and may appear polyhedral (Figure 3A) or spherical (Figure 3B,C) depending on the C-star design used. The morphology of binary condensates is dependent on the properties of the C-star populations used, as described previously30. Figure 3D shows binary condensates expectedly exhibiting phase separation, observable in bright field imaging. The presence of air bubbles in the capillary tube can also interfere with the self-assembly of the condensates, often resulting in aggregation near the air interface (Figure 4A,B). Incorrectly prepared mixtures, such as those lacking oligonucleotide components or those prepared with imbalanced stoichiometries, may result in condensates not forming at all or forming non-spherical connected networks or aggregates as in Figure 4C. Similarly, incorrectly prepared binary condensates can exhibit aggregation and networks, and may also exhibit no observable phase separation, as shown in Figure 4D.

For transcription of RNA light-up aptamers, a successful outcome will be observed by monitoring the increase in fluorescence of the fluorogen over time, for example via microscopy (Figure 5) or spectrophotometry.

Figure 3
Figure 3: Representative micrographs showing annealed C-star condensates. (A) Bright field micrograph and inset showing condensates formed from a non-responsive C-star with an arm length of 28 base pairs. Here we note the polyhedral morphology which reflects the crystalline order of smaller C-stars32. (B) Bright field micrograph and inset showing condensates formed from a TMSD-responsive C-star, with an arm length of 50 base pairs. These condensates are broadly spherical, though many show a more irregular morphology indicative of multiple condensates merging, as is expected for larger C-stars which tend to be more fluid32. (C) Bright field micrograph and inset showing condensates formed from a non-responsive C-star with an arm length of 35 base pairs. These condensates appear spherical, though small angle X-ray scattering data from previous work shows that their microstructure is crystalline32. (D) Bright field micrograph and inset showing binary condensates formed from a combination of the C-star populations also used in panels (B) and (C). The combination of these two populations leads to the formation of condensates with distinct phase separation, visible without fluorescent labelling. Other combinations may not exhibit phase separation, as described in previous work30. Please click here to view a larger version of this figure.

Figure 4
Figure 4: Micrographs showing common issues encountered with incorrectly prepared condensates. (A) Bright field micrographs showing condensates formed from a non-responsive C-star with an arm length of 28 base pairs (which formed successfully in Figure 3A) in the presence of an air bubble in the capillary tube. The panel is composed of two micrographs stitched at the red dashed line and shows the aggregation of condensates near the air interface. (B) Bright field micrograph showing condensates formed from a TMSD-responsive C-star of arm length 50 base pairs (which formed successfully in Figure 3B) in the presence of an air bubble in the capillary tube. Here, the condensates have merged to form a continuous interconnected network due to the more fluid nature of condensates composed of larger C-star motifs32. (C) Bright field micrograph showing condensates formed from a non-responsive C-star with an arm length of 35 base pairs (which formed successfully in Figure 3C). The morphology is irregular and angular, indicating an error in preparation, possibly imbalanced stoichiometries. (D) Bright field micrograph of binary condensates formed from a combination of the C-star populations as in Fig. 3D. These condensates are highly connected, as in panel (C), and also do not exhibit the expected phase separation (see Figure 3D), indicating an error in their preparation. While the exact sources of errors are difficult to pinpoint, incorrect stoichiometries or the use of incorrect oligonucleotide sequences are potential causes. Please click here to view a larger version of this figure.

Figure 5
Figure 5: Representative results from the transcription of an embedded DNA template for an RNA aptamer. Timelapse showing the synthesis of the Broccoli light-up aptamer via the transcription of a DNA template embedded in condensates made from the C-star motif described in Figure 1C. The aptamer binds to the DFHBI present in the transcription mixture, inducing an increase in fluorescence over time. Notable here is a change in morphology of the condensate over time, which appears to form a core-shell structure. This phenomenon is likely due to swelling of the condensate's outer layer due to a transient osmotic pressure imbalance associated to local production of the RNA aptamer. Aptamer production may occur preferentially in the outer layers of the condensates due to the reported tendency of the aptamer template strand to accumulate in this region30. Please click here to view a larger version of this figure.

Supplementary Table 1: Sequence details for various designs of single components. Please click here to download this File.

Supplementary Table 2: Volume of components for each design. Please click here to download this File.

Discussion

The protocol described here provides an approach for the preparation of one- or two- component condensates from amphiphilic DNA nanostars, with design variations to introduce different responses into the condensates. The given protocol produces condensates in a buffer solution of 0.3 M NaCl in TE, but the buffer conditions can be amended by appropriately modifying the volumes listed above. Previous work has studied the formation of C-star condensates in 0.2 M NaCl in TE and 0.1 M NaCl in TE and in phosphate-buffered saline (PBS)32. The C-star condensates are produced at an end concentration of 5 µM, but this too can be varied by appropriately modifying oligonucleotide concentrations and/or volumes added in the protocol above. Depending on the variations desired, it may be necessary to prepare oligonucleotide stock solutions at different concentrations and in different buffers compared to the protocol described in section 1, though the practical aspects of the protocol remain the same. C-star design can be readily modified to introduce a different functionality or response, as detailed in previous work32. Design variations include the introduction of motifs that respond to pH changes32, potassium ions31, or oligonucleotide sequences30,32. Should new designs be desired, it is advised to first test the assembly computationally (using tools such as NUPACK39) and then test the formation of the equivalent, non-cholesterolized nanostars using agarose gel electrophoresis32,40. The extent of phase separation in binary condensates will depend on the combination of C-star populations used, as described in previous work30. We note that the annealing protocols specified for condensate formation require timescales far longer than those typical for folding small DNA nanostructures similar to individual C-stars. Slow annealing is indeed required to enable equilibration over the larger length scales of the condensates. For single-component condensates, the suggested protocol has a duration of 17 h, and for binary condensates, an even longer annealing protocol (~3 days) is used to approach thermodynamic equilibrium. We have found that these protocols yield reproducible results across all different C-star populations used to date, but should researchers wish to improve sample throughput, we would recommend a systematic study where annealing rates are modulated to find the shortest possible protocol where the desired morphologies can be achieved for the system under test. It is recommended that the 30 min hold at 95 °C is left unmodified, since this step effectively sterilizes the sample and enables long-term storage in capillary tubes.

The chamber in which C-star condensates are produced is crucial to their successful formation. The chamber should be made from glass or quartz; the use of plastic containers such as polypropylene, a typical material for microcentrifuge tubes, will disrupt self-assembly due to hydrophobic interactions between the plastic and the cholesterol moieties. The aspect ratio of the annealing container and the concentration of the C-star mixture will also affect the characteristics of the condensates, particularly their size and aggregation. Specifically, if a "taller" container is used, with a small surface area at the bottom relative to its height, C-star condensates will sediment at the bottom with high surface densities, which will favor the formation of contact points between condensates. If these occur late in the thermal annealing process, when the temperature is relatively low, and the condensates either behave as highly viscous liquids or solids, touching condensates will fail to relax into spherical shapes and rather form irregular aggregates of partially coalesced configurations. When pipetting the C-star mixture into capillary tubes, care should be taken to avoid the introduction of air bubbles – large aggregates tend to form at the air/water interface, so the extracted condensates will have non-ideal size and morphology. Drying the ends of the capillary tubes after the injection of the C-star mixture or mineral oil will lead to improved adhesion. The adhesive selected must be viscous enough to completely coat the capillary tube openings without being wicked into the tube, inert to mineral oil, compatible with glass, and stable at the annealing temperatures used. We have found that the two-part Araldite Rapid epoxy adhesive is suitable for our purposes despite only being rated to temperatures of 80 °C. Air bubbles or gaps in the glue will lead to imperfectly sealed capillaries, which tend to leak during annealing. After the glue has cured, wrapping the samples in aluminum foil has the dual benefit of containing any leaks and improving thermal contact between the sample and the thermal cycler. The foil should be kept as smooth and flat as possible to ensure the capillaries are kept level during annealing. Annealed condensates in capillaries can be stored long-term at room temperature and re-annealed if necessary. Samples should be handled carefully – the condensates are likely to coalesce when in contact, so capillaries should be stored flat. For optimal microscopy imaging, the coverslip can be scored and removed while leaving the capillary tubes intact. Condensates tend to be larger than 5 µm in diameter, and we have not observed significant Brownian motion during their imaging29,30.

It is recommended to prepare multiple independent batches of C-star condensates to ensure possible differences observed between samples reflect differences in either composition or annealing conditions, and not differences caused by potential experimental errors.

Small glass particles will likely be introduced into the condensate solution as a result of the extraction process. These can be minimized by carefully dabbing the cut ends of the capillary tube with a clean strip of Parafilm, which is highly effective at picking up glass, prior to placing the cut capillary tube into the microcentrifuge tube containing the buffer solution. During extraction, the number of condensates extracted can be maximized by briefly spinning down the microcentrifuge tube containing the cut capillary tube, though this does increase the likelihood of condensates coalescing and forming non-ideal morphologies. After extraction, condensates should be stored at refrigerator temperatures (typically 4 °C) and used within three days to avoid potential issues with biological contamination and because condensates in microcentrifuge tubes will aggregate and coalesce over time due to the typically rounded or pointed shapes of these tubes. Very vigorous pipetting of extracted condensates should be avoided, as they can be damaged by excessive shear flow.

For the transcription of an RNA aptamer, it may be necessary to modify the volume of the transcription mixture used since the number and size of condensates (and, therefore, the concentration of template) in each individual reaction cannot be precisely controlled. In the experiments described in section 3, an excess of transcription mixture is used relative to the theoretical template concentration. It is recommended that the supernatants from the three wash steps (section 3.1) are retained and used to carry out transcription reactions. These experiments will give an indication of the amount of unbound aptamer template present in the solution.

One of the main advantages of the C-star platform is its flexibility and modularity. As described above and in previous work, condensates can be designed to respond to a range of inputs, such as toehold-mediated strand displacement and RNA aptamer transcription separately or in sequence. Combined with the inherent programmability of its DNA building blocks, amphiphilic DNA nanostars provide a robust and versatile solution for the design and preparation of synthetic cells.

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

LM, LDM, and DT acknowledge support from the European Research Council (ERC) under the Horizon 2020 Research and Innovation Programme (ERC-STG No 851667 – NANOCELL). LDM acknowledges support from a Royal Society Research Grant for Research Fellows (RGF/R1/180043) and support from a Royal Society University Research Fellowship (UF160152, URF/R/221009).

Materials

0.22 μm syringe filters Sigma-Aldrich SLGVR33RB
24 x 60 mm #1.5 Rectangular cover glasses, Menzel Gläser VWR 631-0853
2-Propanol Sigma-Aldrich 34683
6 L Ultrasonic Cleaner with Digital Timer and Heat, 230 VAC Cole-Parmer WZ-08895-11
Araldite Rapid Adhesive 2 Part Epoxy Glue RS ARA-400005
Bio-Rad C1000 thermal cycler Bio-Rad 1851197
Brand Microcentrifuge Tube 2 mL with Locking Lid Fisher Scientific 15338665 2 mL microcentrifuge tubes for the extraction of C-star condensates
Diamond Scribing Pen RS 394-217
Difluoro-4-hydroxybenzylidene imidazolidinone (DFHBI) Sigma-Aldrich SML1627
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 472301
Eppendorf PCR Clean Colorless Safe-Lock Centrifuge Tubes Fisher Scientific 0030123301 0.5 mL microcentrifuge tubes for the preparation of C-star mixtures
Ethanol Absolute 99.8+% Fisher Scientific 10437341 70% ethanol is sufficient for cleaning purposes
Fisherbrand ZX4 IR Vortex Mixer Fisherbrand 13284769
Hellmanex III Hellma 9-307-011-4-507
Hollow Rectangle Capillaries ID 0.40 x 4.00 mm, 50 mm in length CM Scientific 2540-50
Mineral oil Sigma-Aldrich 69794
Mini Centrifuge, 230 V PRISM(TM) Z763128
NaCl Sigma-Aldrich S3014
NanoDrop One Spectrophotometer Thermo Fisher Scientific ND-ONE-W Used to measure absorbance of oligonucleotides for concentration calculations
Oligonucleotides Integrated DNA Technologies Custom Oligonucleotide sequences are unique to the C-star design required.
ScriptGuard RNase inhibitor CELLSCRIPT C-SRI6310K RNase inhibitor
T7-FlashScribe Transcription Kit Cambio C-ASF3507
Tris-EDTA buffer, 100x stock solution Sigma-Aldrich 574793
UltraPure DNase/RNase-Free Distilled Water Invitrogen 10977035
VWR Spec-Wipe 3 Wipers VWR 21914-758

Riferimenti

  1. Buddingh’, B. C., Hest, J. C. M. v. Artificial cells: Synthetic compartments with life-like functionality and adaptivity. Acc Chem Res. 50 (4), 769-777 (2017).
  2. Fanalista, F., et al. Shape and size control of artificial cells for bottom-up biology. ACS Nano. 13 (5), 5439-5450 (2019).
  3. Dora Tang, T. -. Y., et al. Fatty acid membrane assembly on coacervate microdroplets as a step towards a hybrid protocell model. Nat Chem. 6 (6), 527-533 (2014).
  4. Deshpande, S., et al. Spatiotemporal control of coacervate formation within liposomes. Nat Commun. 10 (1), 1800 (2019).
  5. Rubio-Sánchez, R., et al. Thermally driven membrane phase transitions enable content reshuffling in primitive cells. J Am Chem Soc. 143 (40), 16589-16598 (2021).
  6. Jahnke, K., Huth, V., Mersdorf, U., Liu, N., Göpfrich, K. Bottom-up assembly of synthetic cells with a DNA cytoskeleton. ACS Nano. 16 (5), 7233-7241 (2022).
  7. Tran, M. P., et al. A DNA segregation module for synthetic cells. Small. 19 (13), 2202711 (2023).
  8. Mason, A. F., Buddingh’, B. C., Williams, D. S., Hest, J. C. M. v. Hierarchical self-assembly of a copolymer-stabilized coacervate protocell. J Am Chem Soc. 139 (48), 17309-17312 (2017).
  9. Gumz, H., et al. Toward functional synthetic cells: In-depth study of nanoparticle and enzyme diffusion through a cross-linked polymersome membrane. Adv Sci. 6 (7), 1801299 (2019).
  10. Huang, X., Patil, A. J., Li, M., Mann, S. Design and construction of higher-order structure and function in proteinosome-based protocells. J Am Chem Soc. 136 (25), 9225-9234 (2014).
  11. Booth, R., Qiao, Y., Li, M., Mann, S. Spatial positioning and chemical coupling in coacervate-in-proteinosome protocells. Angew Chem Int Ed Engl. 58 (27), 9120-9124 (2019).
  12. Hindley, J. W., et al. Light-triggered enzymatic reactions in nested vesicle reactors. Nat Commun. 9 (1), 1093 (2018).
  13. Zubaite, G., Hindley, J. W., Ces, O., Elani, Y. Dynamic reconfiguration of subcompartment architectures in artificial cells. ACS Nano. 16 (6), 9389-9400 (2022).
  14. Hirose, T., et al. A guide to membraneless organelles and their various roles in gene regulation. Nat Rev Mol Cell Biol. 24 (4), 288-304 (2023).
  15. Guindani, C., Silva, L. C. d., Cao, S., Ivanov, T., Landfester, K. Synthetic cells: From Simple Bio-Inspired Modules to Sophisticated Integrated Systems. Angew Chem Int Ed Engl. 61 (16), e202110855 (2022).
  16. Adamala, K. P., et al. Present and future of synthetic cell development. Nat Rev Mol Cell Biol. 25 (3), 162-167 (2023).
  17. Allen, M. E., et al. Biomimetic behaviors in hydrogel artificial cells through embedded organelles. Proc Natl Acad Sci U S A. 120 (35), e2307772120 (2023).
  18. Cook, A. B., Novosedlik, S., Hest, J. C. M. v. Complex coacervate materials as artificial cells. Acc Mater Res. 4 (3), 287-298 (2023).
  19. Seeman, N. C., Sleiman, H. F. DNA nanotechnology. Nat Rev Mater. 3, 17068 (2018).
  20. Takinoue, M. DNA droplets for intelligent and dynamical artificial cells: from the viewpoint of computation and non-equilibrium systems. Interface Focus. 13 (5), 20230021 (2023).
  21. Liu, W., Lupfer, C., Samanta, A., Sarkar, A., Walther, A. Switchable hydrophobic pockets in DNA protocells enhance chemical conversion. J Am Chem Soc. 145 (13), 7090-7094 (2023).
  22. Wilner, O. I., Willner, I. Functionalized DNA nanostructures. Chem Rev. 112 (4), 2528-2556 (2012).
  23. Gong, J., Tsumura, N., Sato, Y., Takinoue, M. Computational DNA droplets recognizing miRNA sequence inputs based on liquid-liquid phase separation. Adv Funct Mater. 32, 2202322 (2022).
  24. Jeon, B. -. J., Nguyen, D. T., Saleh, O. A. Sequence-controlled adhesion and microemulsification in a two-phase system of DNA liquid droplets. J Phys Chem. 124 (40), 8888-8895 (2020).
  25. Sato, Y., Sakamoto, T., Takinoue, M. Sequence-based engineering of dynamic functions of micrometer-sized DNA droplets. Sci Adv. 6 (23), 3471 (2020).
  26. Saleh, O. A., et al. Vacuole dynamics and popping-based motility in liquid droplets of DNA. Nat Commun. 14 (1), 3574 (2023).
  27. Rubio-Sánchez, R., Fabrini, G., Cicuta, P., Michele, L. D. Amphiphilic DNA nanostructures for bottom-up synthetic biology. Chem Commun. 57 (95), 12725-12740 (2021).
  28. Brady, R. A., Brooks, N. J., Cicuta, P., Di Michele, L. Crystallization of amphiphilic DNA C-Stars. Nano Lett. 17 (5), 3276-3281 (2017).
  29. Leathers, A., et al. Reaction-diffusion patterning of DNA-based artificial cells. J Am Chem Soc. 144 (38), 17468-17476 (2022).
  30. Malouf, L., et al. Sculpting DNA-based synthetic cells through phase separation and phase-targeted activity. Chem. 9 (11), 3347-3364 (2023).
  31. Fabrini, G., Minard, A., Brady, R. A., Antonio, M. D., Michele, L. D. Cation-responsive and photocleavable hydrogels from noncanonical amphiphilic DNA nanostructures. Nano Lett. 22 (2), 602-611 (2022).
  32. Brady, R. A., Brooks, N. J., Foderà, V., Cicuta, P., Di Michele, L. Amphiphilic-DNA platform for the design of crystalline frameworks with programmable structure and functionality. J Am Chem Soc. 140 (45), 15384-15392 (2018).
  33. Walczak, M., et al. Responsive core-shell DNA particles trigger lipid-membrane disruption and bacteria entrapment. Nat Commun. 12 (1), 4743 (2021).
  34. Zhang, D. Y., Winfree, E. Control of DNA strand displacement kinetics using Toehold exchange. J Am Chem Soc. 131 (47), 17303-17314 (2009).
  35. . Integrated DNA Technologies OligoAnalyzer Tool Available from: https://www.idtdna.com/pages/products/custom-dna-rna/dna-oligos/custom-dna-oligos (2024)
  36. Cavaluzzi, M. J., Borer, P. N. Revised UV extinction coefficients for nucleoside-5′-monophosphates and unpaired DNA and RNA. Nucleic Acids Res. 32 (1), e13 (2004).
  37. Lattuada, E., Caprara, D., Piazza, R., Sciortino, F. Spatially uniform dynamics in equilibrium colloidal gels. Sci Adv. 7 (49), (2021).
  38. . T7-FlashScribeTM Transcription Kit Available from: https://www.cellscript.com/products/018pl0617CS.pdf (2017)
  39. Zadeh, J. N., et al. NUPACK: Analysis and design of nucleic acid systems. J Comput Chem. 32 (1), 170-173 (2011).
  40. Walczak, M., Brady, R. A., Leathers, A., Kotar, J., Di Michele, L. Influence of hydrophobic moieties on the crystallization of amphiphilic DNA nanostructures. The Journal of Chemical Physics. 158 (8), 084501 (2023).

Play Video

Citazione di questo articolo
Malouf, L., Tanase, D. A., Di Michele, L. Synthetic Condensates and Cell-Like Architectures from Amphiphilic DNA Nanostructures. J. Vis. Exp. (207), e66738, doi:10.3791/66738 (2024).

View Video